Emerging Trends Reshaping the Future of the UK Biologics Industry

added blog Sağlık

2026-06-09 05:41:13

Cost sustainability remains a central theme within the UK's public healthcare model, directly influencing how biological therapies are adopted and distributed. With several blockbuster reference biologics facing patent expirations over the coming decade, the spotlight has firmly shifted toward biosimilars—highly similar, more affordable versions of approved biological medicines. The NHS...

0 Comments 0 Shares 47 Views 0 Reviews